Pipeline 1: target → molecules
- Start with a disease-relevant target.
- denovoX explores chemical space through an ensemble of ML approaches.
- Receive prioritized molecule candidates for follow-up work.
AI-native in silico drug design
denovoX pairs two high-level pipelines: target to molecules and molecule to targets, helping teams de-risk discovery through computational prioritization before wet-lab investment.
Platform access is now routed through private-preview user accounts.
Conceptual flow overview
Pipelines
Benefits
Reduce broad experimental search space by prioritizing candidates before intensive wet-lab allocation.
Move from hypotheses to ranked options quickly, supporting tighter decision loops across discovery teams.
Use predicted target and off-target patterns to spot potential risk signals earlier in exploratory stages.
Who we serve
Support portfolio triage and early-stage prioritization with computationally ranked candidate insights.
Create accountFocus limited resources on the most promising hypotheses and reduce exploratory dead ends.
Create accountAccelerate translational exploration with a practical in silico layer for candidate and target assessment.
Create accountTrust and validation
MVP currently tested by 3 labs at Nazarbayev University.
Built on high-performance infrastructure with deployment flexibility across major cloud providers.
Account access
Workspace preview
After sign-in, users land on an account workspace with placeholder entries for the connected VPS tool environment while the integration surface is finalized.